Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
about
Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategiesThe nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation tissue contractionThe role of osteopontin and osteopontin aptamer (OPN-R3) in fibroblast activity.Genome-wide transcriptional analysis of differentially expressed genes in diabetic, healing corneal epithelial cells: hyperglycemia-suppressed TGFβ3 expression contributes to the delay of epithelial wound healing in diabetic corneas.A Multicenter Randomized Controlled Trial Evaluating a Cx43-Mimetic Peptide in Cutaneous Scarring.
P2860
Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
@en
Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
@nl
type
label
Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
@en
Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
@nl
prefLabel
Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
@en
Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
@nl
P2093
P2860
P356
P1476
Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
@en
P2093
Mark W J Ferguson
Nick L Occleston
Sharon O'Kane
Tracey Mason
P2860
P356
10.1155/2010/690613
P577
2010-08-03T00:00:00Z